Henry Schein (HSIC) Scheduled to Post Quarterly Earnings on Tuesday

Henry Schein (NASDAQ:HSIC - Get Free Report) will be announcing its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.99 per share for the quarter. Henry Schein has set its FY 2024 guidance at 5.000-5.160 EPS and its FY24 guidance at $5.00 to $5.16 EPS.Persons that are interested in registering for the company's earnings conference call can do so using this link.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.70 by ($0.04). The company had revenue of $3.02 billion during the quarter, compared to analysts' expectations of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein's revenue was down 10.5% on a year-over-year basis. During the same period last year, the firm posted $1.21 earnings per share. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Henry Schein Stock Down 5.1 %

Shares of HSIC traded down $3.75 during mid-day trading on Tuesday, hitting $69.28. 1,720,426 shares of the company's stock were exchanged, compared to its average volume of 1,083,191. The company has a market cap of $8.90 billion, a price-to-earnings ratio of 23.18, a P/E/G ratio of 1.81 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The stock's 50-day moving average is $74.12 and its 200-day moving average is $72.41.

Insider Activity at Henry Schein

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm's stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm's stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company's stock, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Jefferies Financial Group upped their price target on Henry Schein from $74.00 to $81.00 and gave the stock a "hold" rating in a report on Wednesday, March 6th. Piper Sandler lifted their price target on Henry Schein from $78.00 to $86.00 and gave the stock an "overweight" rating in a research note on Monday, February 26th. TheStreet raised shares of Henry Schein from a "c+" rating to a "b-" rating in a research note on Monday, February 26th. Evercore ISI upped their price target on shares of Henry Schein from $79.00 to $83.00 and gave the stock an "in-line" rating in a research report on Wednesday, February 28th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an "overweight" rating in a report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $81.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.